Skip Navigation

VAERS Bibliography - March 2002

  1. From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices JAMA.  2002, %20;287 (7): 833-834.

  2. From the Centers for Disease Control and Prevention. Supply diphtheria and tetanus toxoids and acellular pertussis vaccine  JAMA.  2-6-2002, 287 (5): 579.

  3. From the Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax  JAMA.  2-6-2002, 287 (5): 579.

  4. Small improvements seen in patient, staff vaccinations  Nephrol.News Issues.  2002, 16 (3): 18-25.

  5. Pertussis--United States, 1997-2000  MMWR CDC Surveill Summ.  2-1-2002, 51 (4): 73-76.

  6. Immunization registry use and progress--United States, 2001  MMWR Morb.Mortal.Wkly.Rep.  1-25-2002, 51 (3): 53-56.

  7. Aribas, O. K., Kanat, F., Gormus, N., and Turk, E.  Cold abscess of the chest wall as an unusual complication of BCG vaccination  Eur.J.Cardiothorac.Surg.  2002, 21 (2): 352-354.

  8. Atkinson, W. L., Pickering, L. K., Schwartz, B., Weniger, B. G., Iskander, J. K., and Watson, J. C.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)  MMWR Morb.Mortal.Wkly.Rep.  2-8-2002, 51 (RR-2): 1-35.

  9. Cook, I. F. and Murtagh, J.  Paediatric vaccination practice in a division of general practice  Aust.Fam.Physician.  2001, 30 (12): 1185-1189.

  10. Dalpke, A., Zimmermann, S., and Heeg, K.  CpG-oligonucleotides in vaccination: signaling and mechanisms of action  Immunobiology.  2001, 204 (5): 667-676.

  11. Diodati, C.  Mandatory vaccination of health care workers  CMAJ.  2-5-2002, 166 (3): 301-302.

  12. Downes, K. A., Domen, R. E., McCarron, K. F., and Bringelsen, K. A.  Acute autoimmune hemolytic anemia following DTP vaccination: report of a fatal case and review of the literature  Clin.Pediatr.(Phila).  2001, 40 (6): 355-358.

  13. Eaton, L. 
    New research on autism and measles "proves nothing"  BMJ.  2-9-2002, 324 (7333): 315.

  14. Garcia-Doval, I., Roson, E., Feal, C., De la, Torre C., Rodriguez, T., and Cruces, M. J.  Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid  Acta Derm.Venereol.  2001, 81 (6): 450-451.

  15. Grabenstein, J. D., Guess, H. A., Hartzema, A. G., Koch, G. G., and Konrad, T. R.  Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated  J.Clin.Epidemiol.  2002, 55 (3): 279-284.

  16. Hanna, J. N., Young, D. M., Brookes, D. L., Dostie, B. G., and Murphy, D. M.  The initial coverage and impact of the pneumococcal and influenza vaccination program for at-risk indigenous adults in Far North Queensland  Aust.N.Z.J.Public Health.  2001, 25 (6): 543-546.

  17. Howe, M.  Pneumoccocal vaccination programme begins in Australia  Lancet Infect.Dis.  2001, 1 (2): 69.

  18. Krishna, M. T. and Salvi, S. S.  BCG vaccination and prevention of allergic disease  Pediatrics.  2002, 109 (2): 346-347.

  19. Lathrop, S. L., Ball, R., Haber, P., Mootrey, G. T., Braun, M. M., Shadomy, S. V., Ellenberg, S. S., Chen, R. T., and Hayes, E. B.  Adverse event reports following vaccination for Lyme disease: December 1998--July 2000  Vaccine.  2-22-2002, 20 (11-12): 1603-1608.

  20. Leask, J. and Chapman, S.  'The cold hard facts' immunisation and vaccine preventable diseases in Australia's newsprint media 1993-1998  Soc.Sci.Med.  2002, 54 (3): 445-457.

  21. Lewis, P. R., Reimer, R. F., and Dixon, A. J.  Evaluating the efficacy of vaccine storage in the general practice setting  Aust.N.Z.J.Public Health.  2001, 25 (6): 547-550.

  22. Libman, M. D., Ibrahim, S. A., Omer, M. I., Adlan, I. A., Bellavance, F., Hoskins, E., Bertley, F., and Ward, B. J.  No evidence for short or long term morbidity after increased titer measles vaccination in Sudan  Pediatr.Infect.Dis.J.  2002, 21 (2): 112-119.

  23. Marufu, T. and Siziya, S.  Impact of multiple dose measles vaccination on measles transmission patterns in Gweru, Zimbabwe  J.Trop.Pediatr.  2001, 47 (6): 335-338.

  24. Mazzone, P. J., Mossad, S. B., Mawhorter, S. D., Mehta, A. C., Schilz, R. J., and Maurer, J. R.  The humoral immune response to influenza vaccination in lung transplant patients  Eur.Respir.J.  2001, 18 (6): 971-976.

  25. Morfin, F., Beguin, A., Lina, B., and Thouvenot, D.  Detection of measles vaccine in the throat of a vaccinated child  Vaccine.  2-22-2002, 20 (11-12): 1541-1543.

  26. Mrsny, R. J., Daugherty, A. L., McKee, M. L., and FitzGerald, D. J.  Bacterial toxins as tools for mucosal vaccination  Drug Discov.Today.  2-15-2002, 7 (4): 247-258.

  27. Raaska, K., Raitasuo, V., and Neuvonen, P. J.  Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia  Eur.J.Clin.Pharmacol.  2001, 57 (10): 705-708.

  28. Reinert, P.  The role of pneumococcal and haemophilus type B vaccination in the prevention of acute otitis media  Clin.Microbiol.Infect.  1997, 3 Suppl 3:S59-S61. (): S59-S61.

  29. Riddell, M. A., Leydon, J. A., Ugoni, A., and Kelly, H. A.  A serosurvey evaluation of the school-based measles 'catch-up' immunisation campaign in Victorian school-aged children  Aust.N.Z.J.Public Health.  2001, 25 (6): 529-533.

  30. Rokicka-Milewska, R., Machala, M., Klukowska, A., Laguna, P., and Sikorska-Fic, B.  Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia  Clin.Microbiol.Infect.  1998, 4 (10): 589-593.

  31. Seward, J. F., Watson, B. M., Peterson, C. L., Mascola, L., Pelosi, J. W., Zhang, J. X., Maupin, T. J., Goldman, G. S., Tabony, L. J., Brodovicz, K. G., Jumaan, A. O., and Wharton, M.  Varicella disease after introduction of varicella vaccine in the United States, 1995-2000  JAMA.  2-6-2002, 287 (5): 606-611.

  32. Shah, S., Raman, S., Moreira, C., and MacIntyre, C. R.  School immunisation certificates--a review over time in a disadvantaged community  Aust.N.Z.J.Public Health.  2001, 25 (6): 534-538.

  33. Stephenson, J.  Experts focus on infective agents of bioterrorism  JAMA.  2-6-2002, 287 (5): 575-576.

  34. Strine, T. W., Barker, L. E., Jain, R. B., Washington, M. L., Chu, S. Y., and Mokdad, A. H.  Extraimmunization in children through 2000  JAMA.  2-6-2002, 287 (5): 588-589.

  35. Taylor, B., Miller, E., Lingam, R., Andrews, N., Simmons, A., and Stowe, J.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study  BMJ.  2-16-2002, 324 (7334): 393-396.

  36. Tillmann, B. U., Tillmann, H. C., Nars, P. W., and Weber, P.  Vaccination rate and age of premature infants weighing <1500 g: a pilot study in north-western Switzerland  Acta Paediatr.  2001, 90 (12): 1421-1426.

  37. Tukuitonga, C.  Meningococcal vaccine  N.Z.Med.J.  12-14-2001, 114 (1145): 557.

  38. Uhari, M.  Review: varicella vaccination is effective in children  ACP J.Club.  2002, 136 (1): 25.

  39. Verweij, M. and van Den, Hoven M.  Influenza vaccination rates and informed consent in Dutch nursing homes: survey of nursing home physicians  BMJ.  2-9-2002, 324 (7333): 328.

  40. Weir, E.  Streptococcus pneumoniae infection in children: vaccine implications  CMAJ.  1-22-2002, 166 (2): 220.

  41. Yoshiyama, T.  [Comparison of effectiveness of BCG vaccination and preventive therapy in Japanese settings, with special emphasis on the sensitivity and specificity of tuberculin testing]  Kekkaku.  2002, 77 (1): 11-22.